Hemodynamic Determinants of Elevated Blood Pressure and Hypertension in the Middle to Older-Age UK Population: A UK Biobank Imaging Study.

aortic distensibility blood pressure cardiac output hemodynamic hypertension systemic vascular resistance

Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
11 2023
Historique:
medline: 23 10 2023
pubmed: 7 9 2023
entrez: 7 9 2023
Statut: ppublish

Résumé

Increased systemic vascular resistance and, in older people, reduced aortic distensibility, are thought to be the hemodynamic determinants of primary hypertension but cardiac output could also be important. We examined the hemodynamics of elevated blood pressure and hypertension in the middle to older-aged UK population participating in the UK Biobank imaging studies. Cardiac output, systemic vascular resistance, and aortic distensibility were measured from cardiac magnetic resonance imaging in 31 112 (distensibility in 21 178) participants (46.3% male, mean age±SD 63±7 years). Body composition including visceral adipose tissue volume and abdominal subcutaneous adipose tissue volume were measured in 19 645 participants. Participants with higher blood pressure had higher cardiac output (higher by 17.9±26.6% in hypertensive compared with those with optimal blood pressure) and higher systemic vascular resistance (higher by 11.4±27.9% in hypertensive compared with those with optimal blood pressure). These differences were little changed after adjustment for body size and adiposity. The contribution of cardiac output relative to systemic vascular resistance was more marked in younger compared with older subjects. Aortic distensibility decreased with age and was lower in participants with higher compared with lower blood pressure but with a greater difference in younger compared with older subjects. In the middle to older-aged UK population, cardiac output plays an important role in contributing to elevated mean arterial blood pressure, particularly in younger compared with older subjects. Reduced aortic distensibility contributes to a rise in pulse pressure and systolic blood pressure at all ages.

Sections du résumé

BACKGROUND
Increased systemic vascular resistance and, in older people, reduced aortic distensibility, are thought to be the hemodynamic determinants of primary hypertension but cardiac output could also be important. We examined the hemodynamics of elevated blood pressure and hypertension in the middle to older-aged UK population participating in the UK Biobank imaging studies.
METHODS
Cardiac output, systemic vascular resistance, and aortic distensibility were measured from cardiac magnetic resonance imaging in 31 112 (distensibility in 21 178) participants (46.3% male, mean age±SD 63±7 years). Body composition including visceral adipose tissue volume and abdominal subcutaneous adipose tissue volume were measured in 19 645 participants.
RESULTS
Participants with higher blood pressure had higher cardiac output (higher by 17.9±26.6% in hypertensive compared with those with optimal blood pressure) and higher systemic vascular resistance (higher by 11.4±27.9% in hypertensive compared with those with optimal blood pressure). These differences were little changed after adjustment for body size and adiposity. The contribution of cardiac output relative to systemic vascular resistance was more marked in younger compared with older subjects. Aortic distensibility decreased with age and was lower in participants with higher compared with lower blood pressure but with a greater difference in younger compared with older subjects.
CONCLUSIONS
In the middle to older-aged UK population, cardiac output plays an important role in contributing to elevated mean arterial blood pressure, particularly in younger compared with older subjects. Reduced aortic distensibility contributes to a rise in pulse pressure and systolic blood pressure at all ages.

Identifiants

pubmed: 37675583
doi: 10.1161/HYPERTENSIONAHA.122.20969
pmc: PMC10876164
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2473-2484

Subventions

Organisme : Medical Research Council
ID : MR/M016560/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/17/50/32903
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M01656Q/1
Pays : United Kingdom

Références

Heart. 2003 Sep;89(9):1104-9
pubmed: 12923045
J Am Heart Assoc. 2022 Dec 6;11(23):e026361
pubmed: 36444831
Nat Commun. 2020 May 26;11(1):2624
pubmed: 32457287
Physiol Rev. 1982 Apr;62(2):347-504
pubmed: 6461865
Hypertension. 2005 Jul;46(1):221-6
pubmed: 15867140
Circulation. 2003 Jan 7;107(1):139-46
pubmed: 12515756
J Am Coll Cardiol. 2014 Dec 23;64(24):2619-2629
pubmed: 25524341
Circulation. 2007 Jan 16;115(2):221-7
pubmed: 17210838
Circulation. 2003 Sep 30;108(13):1592-8
pubmed: 12975261
Hypertension. 2009 Aug;54(2):414-20
pubmed: 19546377
J Hypertens. 2023 Feb 1;41(2):212-219
pubmed: 36583348
JACC Cardiovasc Imaging. 2020 Mar;13(3):684-695
pubmed: 31326477
Clin Sci (Lond). 1980 Dec;59 Suppl 6:343s-354s
pubmed: 6108816
PLoS One. 2016 Sep 23;11(9):e0163332
pubmed: 27662190
Eur J Prev Cardiol. 2018 Sep;25(13):1351-1359
pubmed: 29808754
Front Cardiovasc Med. 2020 Oct 29;7:544302
pubmed: 33330638
J Cardiovasc Magn Reson. 2016 Feb 01;18:8
pubmed: 26830817
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Hypertension. 2017 Dec;70(6):1176-1182
pubmed: 29084874
Circ Res. 2021 Apr 2;128(7):864-886
pubmed: 33793325
J Hypertens. 2013 Jan;31(1):77-85
pubmed: 23079681

Auteurs

Ye Li (Y)

Department of Clinical Pharmacology, King's College London British Heart Foundation Centre, St. Thomas' Hospital, United Kingdom (Y.L., M.C., P.C.).

Emily Chan (E)

School of Bioengineering and Imaging Science, King's College London, United Kingdom (E.C., E.P.-A., B.R., A.P.K., R.R.).

Esther Puyol-Antón (E)

School of Bioengineering and Imaging Science, King's College London, United Kingdom (E.C., E.P.-A., B.R., A.P.K., R.R.).

Bram Ruijsink (B)

School of Bioengineering and Imaging Science, King's College London, United Kingdom (E.C., E.P.-A., B.R., A.P.K., R.R.).

Marina Cecelja (M)

Department of Clinical Pharmacology, King's College London British Heart Foundation Centre, St. Thomas' Hospital, United Kingdom (Y.L., M.C., P.C.).

Andrew P King (AP)

School of Bioengineering and Imaging Science, King's College London, United Kingdom (E.C., E.P.-A., B.R., A.P.K., R.R.).

Reza Razavi (R)

School of Bioengineering and Imaging Science, King's College London, United Kingdom (E.C., E.P.-A., B.R., A.P.K., R.R.).

Phil Chowienczyk (P)

Department of Clinical Pharmacology, King's College London British Heart Foundation Centre, St. Thomas' Hospital, United Kingdom (Y.L., M.C., P.C.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH